Loading...
XNYS
JNJ
Market cap487bUSD
Dec 04, Last price  
202.48USD
1D
-1.39%
1Q
13.48%
Jan 2017
75.75%
Name

Johnson & Johnson

Chart & Performance

D1W1MN
XNYS:JNJ chart
P/E
34.68
P/S
5.49
EPS
5.84
Div Yield, %
1.81%
Shrs. gr., 5y
-1.98%
Rev. gr., 5y
1.60%
Revenues
88.82b
+4.30%
50,514,000,00053,324,000,00061,095,000,00063,747,000,00061,897,000,00061,587,000,00065,030,000,00067,224,000,00071,312,000,00074,331,000,00070,074,000,00071,890,000,00076,450,000,00081,581,000,00082,059,000,00082,584,000,00078,740,000,00079,990,000,00085,159,000,00088,821,000,000
Net income
14.07b
-59.99%
10,411,000,00011,053,000,00010,576,000,00012,949,000,00012,266,000,00013,334,000,0009,672,000,00010,853,000,00013,831,000,00016,323,000,00015,409,000,00016,540,000,0001,300,000,00015,297,000,00015,119,000,00014,714,000,00020,878,000,00017,941,000,00035,153,000,00014,066,000,000
CFO
24.27b
+6.47%
11,877,000,00014,248,000,00015,249,000,00014,972,000,00016,571,000,00016,385,000,00014,298,000,00015,396,000,00017,414,000,00018,471,000,00019,279,000,00018,767,000,00021,056,000,00022,201,000,00023,416,000,00023,536,000,00023,410,000,00021,194,000,00022,791,000,00024,266,000,000
Dividend
Aug 27, 20241.24 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
IPO date
Sep 25, 1944
Employees
152,700
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122023‑002022‑002021‑002019‑122018‑122017‑122017‑002016‑00
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT